vs

Side-by-side financial comparison of BranchOut Food Inc. (BOF) and TScan Therapeutics, Inc. (TCRX). Click either name above to swap in a different company.

BranchOut Food Inc. is the larger business by last-quarter revenue ($4.0M vs $2.6M, roughly 1.6× TScan Therapeutics, Inc.). BranchOut Food Inc. runs the higher net margin — -50.6% vs -895.1%, a 844.5% gap on every dollar of revenue. On growth, TScan Therapeutics, Inc. posted the faster year-over-year revenue change (286.0% vs 181.9%). BranchOut Food Inc. produced more free cash flow last quarter ($-2.1M vs $-32.2M). Over the past eight quarters, BranchOut Food Inc.'s revenue compounded faster (65.4% CAGR vs -9.7%).

Food Lion is an American regional supermarket chain headquartered in Salisbury, North Carolina, that operates over 1,000 supermarkets in 10 states: Delaware, Georgia, Kentucky, Maryland, North Carolina, South Carolina, Pennsylvania, Tennessee, Virginia, and West Virginia. The chain employs over 82,000 people. It was founded in 1957 as Food Town, a single grocery store in Salisbury. It later expanded to many locations across North Carolina. It was independently operated until it was acquired b...

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel T cell receptor (TCR) immunotherapies for hard-to-treat cancers. Its proprietary platform identifies high-affinity naturally occurring TCRs targeting tumor antigens, with pipeline candidates spanning hematological malignancies and solid tumors, operating in the global oncology therapeutics market.

BOF vs TCRX — Head-to-Head

Bigger by revenue
BOF
BOF
1.6× larger
BOF
$4.0M
$2.6M
TCRX
Growing faster (revenue YoY)
TCRX
TCRX
+104.1% gap
TCRX
286.0%
181.9%
BOF
Higher net margin
BOF
BOF
844.5% more per $
BOF
-50.6%
-895.1%
TCRX
More free cash flow
BOF
BOF
$30.1M more FCF
BOF
$-2.1M
$-32.2M
TCRX
Faster 2-yr revenue CAGR
BOF
BOF
Annualised
BOF
65.4%
-9.7%
TCRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOF
BOF
TCRX
TCRX
Revenue
$4.0M
$2.6M
Net Profit
$-2.0M
$-23.0M
Gross Margin
7.6%
Operating Margin
-47.6%
-929.4%
Net Margin
-50.6%
-895.1%
Revenue YoY
181.9%
286.0%
Net Profit YoY
-36.5%
35.8%
EPS (diluted)
$-0.15
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOF
BOF
TCRX
TCRX
Q4 25
$4.0M
$2.6M
Q3 25
$3.2M
$2.5M
Q2 25
$3.3M
$3.1M
Q1 25
$3.2M
$2.2M
Q4 24
$1.4M
Q3 24
$2.2M
$1.0M
Q2 24
$1.4M
Q1 24
$1.5M
Net Profit
BOF
BOF
TCRX
TCRX
Q4 25
$-2.0M
$-23.0M
Q3 25
$-1.6M
$-35.7M
Q2 25
$-1.6M
$-37.0M
Q1 25
$-918.4K
$-34.1M
Q4 24
$-1.5M
Q3 24
$-1.3M
$-29.9M
Q2 24
$-942.6K
Q1 24
$-1.1M
Gross Margin
BOF
BOF
TCRX
TCRX
Q4 25
7.6%
Q3 25
17.7%
Q2 25
18.4%
Q1 25
17.3%
Q4 24
0.9%
Q3 24
15.4%
Q2 24
10.9%
Q1 24
19.3%
Operating Margin
BOF
BOF
TCRX
TCRX
Q4 25
-47.6%
-929.4%
Q3 25
-44.3%
-1475.6%
Q2 25
-40.8%
-1256.6%
Q1 25
-21.4%
-1669.7%
Q4 24
-80.7%
Q3 24
-41.4%
-3109.8%
Q2 24
-60.6%
Q1 24
-69.9%
Net Margin
BOF
BOF
TCRX
TCRX
Q4 25
-50.6%
-895.1%
Q3 25
-48.8%
-1422.1%
Q2 25
-48.6%
-1201.3%
Q1 25
-28.8%
-1571.9%
Q4 24
-104.5%
Q3 24
-58.3%
-2849.1%
Q2 24
-69.2%
Q1 24
-71.6%
EPS (diluted)
BOF
BOF
TCRX
TCRX
Q4 25
$-0.15
$-0.18
Q3 25
$-0.14
$-0.28
Q2 25
$-0.17
$-0.28
Q1 25
$-0.11
$-0.26
Q4 24
$-0.16
Q3 24
$-0.19
$-0.25
Q2 24
$-0.22
Q1 24
$-0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOF
BOF
TCRX
TCRX
Cash + ST InvestmentsLiquidity on hand
$152.4M
Total DebtLower is stronger
$4.9M
$32.5M
Stockholders' EquityBook value
$5.6M
$123.1M
Total Assets
$14.5M
$228.8M
Debt / EquityLower = less leverage
0.89×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOF
BOF
TCRX
TCRX
Q4 25
$152.4M
Q3 25
$184.5M
Q2 25
$218.0M
Q1 25
$251.7M
Q4 24
Q3 24
$271.1M
Q2 24
Q1 24
Total Debt
BOF
BOF
TCRX
TCRX
Q4 25
$4.9M
$32.5M
Q3 25
$32.4M
Q2 25
$32.3M
Q1 25
$32.2M
Q4 24
Q3 24
$30.6M
Q2 24
Q1 24
Stockholders' Equity
BOF
BOF
TCRX
TCRX
Q4 25
$5.6M
$123.1M
Q3 25
$5.1M
$144.0M
Q2 25
$3.5M
$176.7M
Q1 25
$3.9M
$210.2M
Q4 24
$2.3M
Q3 24
$1.5M
$229.1M
Q2 24
$2.0M
Q1 24
$1.7M
Total Assets
BOF
BOF
TCRX
TCRX
Q4 25
$14.5M
$228.8M
Q3 25
$14.7M
$262.2M
Q2 25
$13.2M
$298.6M
Q1 25
$14.1M
$332.7M
Q4 24
$12.9M
Q3 24
$9.6M
$348.0M
Q2 24
$6.7M
Q1 24
$2.7M
Debt / Equity
BOF
BOF
TCRX
TCRX
Q4 25
0.89×
0.26×
Q3 25
0.23×
Q2 25
0.18×
Q1 25
0.15×
Q4 24
Q3 24
0.13×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOF
BOF
TCRX
TCRX
Operating Cash FlowLast quarter
$-1.9M
$-32.0M
Free Cash FlowOCF − Capex
$-2.1M
$-32.2M
FCF MarginFCF / Revenue
-52.6%
-1253.3%
Capex IntensityCapex / Revenue
4.3%
6.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M
$-139.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOF
BOF
TCRX
TCRX
Q4 25
$-1.9M
$-32.0M
Q3 25
$-1.1M
$-32.5M
Q2 25
$-2.0M
$-33.3M
Q1 25
$-1.9M
$-37.6M
Q4 24
$-1.6M
Q3 24
$-1.9M
$-27.9M
Q2 24
$-853.9K
Q1 24
$-503.6K
Free Cash Flow
BOF
BOF
TCRX
TCRX
Q4 25
$-2.1M
$-32.2M
Q3 25
$-1.2M
$-33.9M
Q2 25
$-2.1M
$-34.5M
Q1 25
$-2.3M
$-39.1M
Q4 24
$-2.3M
Q3 24
$-3.4M
$-29.3M
Q2 24
$-1.4M
Q1 24
$-553.6K
FCF Margin
BOF
BOF
TCRX
TCRX
Q4 25
-52.6%
-1253.3%
Q3 25
-37.4%
-1349.6%
Q2 25
-64.5%
-1123.1%
Q1 25
-72.2%
-1801.8%
Q4 24
-163.6%
Q3 24
-157.9%
-2792.0%
Q2 24
-101.3%
Q1 24
-37.7%
Capex Intensity
BOF
BOF
TCRX
TCRX
Q4 25
4.3%
6.7%
Q3 25
2.6%
56.8%
Q2 25
3.4%
41.6%
Q1 25
11.8%
70.6%
Q4 24
51.1%
Q3 24
70.8%
130.6%
Q2 24
38.6%
Q1 24
3.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons